Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center (INC)
Search grants from Fox Chase Cancer Center (INC)
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Gerontology and Geriatric Medicine
Educational Resource Center and Training Research Interd
Breast Exams: What You Should Know
Provide for Nlm Disk Storage Upgrade
Population Genetics of Interactions
Recently added grants:
Computationally Driven Design of De Novo Genetically Encoded Voltage Indicators
California NeuroAIDS Tissue Network
Sleep and Cardiometabolic Health Disparities at the US/Mexico Border: The Nogales Cardiometabolic Health and Sleep (NoCHeS) Study
Biomechanical Determinants of Hematopoietic Stem Cell Potential
HIV-related Stigma and HIV Clinical Outcomes: Linkage and Mechanisms
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025120-000
Application #
6688661
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center (INC)
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
NIH 2002
N01 CA
Phase I, in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center (INC)
Comments
Be the first to comment on this grant